INTENSIVE SPECIALTY HOSPITAL — History
CCN 192010 | 3-year financial timeline | COVID resilience: 55/100
🛡️ Public data only — no PHI permitted on this instance.
$55M
Latest Revenue (FY2022)
-4.2%
Revenue CAGR (3yr)
-11.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $60M | $55M | $55M | -0.7% | -4.2% |
| Operating Expenses | $65M | $58M | $61M | +5.3% | -2.7% |
| Operating Margin | -8.2% | -5.4% | -11.7% | -116.1% | +0.0% |
| Net Income | $-5M | $-3M | $-6M | -114.7% | +0.0% |
| Licensed Beds | 196 | 196 | 250 | +27.6% | +12.9% |
| Total Patient Days | 44,386 | 34,903 | 37,493 | +7.4% | -8.1% |
| Medicare Day % | 59% | 61% | 64% | +5.1% | +4.1% |
| Medicaid Day % | 25% | 3% | 21% | +601.0% | -8.6% |
COVID Impact & Recovery
Resilience Score: 55/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: -8.2% ($60M → $55M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-4.2%
This Hospital
+7.6%
State Avg
Latest Margin
-11.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $52M | -13.4% |
| FY2024 (proj) | $50M | -15.1% |
| FY2025 (proj) | $47M | -16.8% |